Nautilus Neurosciences Overview
- Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
22

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$48.7M
Nautilus Neurosciences General Information
Description
Developer of non-steroidal anti-inflammatory medicine. The company engages in the development and sale of a prescription medicine which is use to treat migraine attacks in adults.
Contact Information
Website
www.nautilusneurosciences.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Acquirer
Primary Office
- Route 202/206
- Bedminster Township, NJ 07921
- United States
Nautilus Neurosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 31-Dec-2013 | $48.7M | 000.00 | 000.00 | Completed | Startup |
3. Debt - General | 05-Dec-2012 | 000.00 | 000.00 | Completed | Startup | |
2. Early Stage VC (Series B) | 08-Apr-2010 | $17.8M | $32.2M | Completed | Startup | |
1. Early Stage VC (Series A) | 23-Nov-2009 | $14.5M | $14.5M | Completed | Startup |
Nautilus Neurosciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of non-steroidal anti-inflammatory medicine. The company engages in the development and sale of a prescription
Drug Discovery
Bedminster Township, NJ
22
As of 2014
000.00
00.00
0000-00-00
000000&0
000.00
Nautilus Neurosciences Competitors (21)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Otonomy | Formerly VC-backed | San Diego, CA | 00 | 00000 | 000000 - 000 | 00000 |
0000000 | Venture Capital-Backed | Framingham, MA | 00 | 000.00 | 00000000000 | 000.00 |
000000 00000000000 | Venture Capital-Backed | Amsterdam, Netherlands | 00.000 | 00000000000 | 00.000 | |
0000000 | Formerly PE-Backed | Hayward, CA | 00 | 00000 | 0000000000. | |
000000 | Venture Capital-Backed | Branford, CT | 00 | 000.00 | 0000000000 0 | 000.00 |
Nautilus Neurosciences Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
William Maichle | Chief Executive Officer & Board Member | ||
Neil Milano | Chief Financial Officer |
Nautilus Neurosciences Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
John Groom | Self | Board Member | 000 0000 |
Peter Lankau | Self | Executive Chairman of the Board | 000 0000 |
William Maichle | Nautilus Neurosciences | Chief Executive Officer & Board Member | 000 0000 |
Nautilus Neurosciences Signals
Nautilus Neurosciences Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Galen Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Tailwind Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |
Nautilus Neurosciences Investments (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 00000000 | 14-Dec-2009 | 0000000000 | Buildings and Property | ||
000000 000000 | 24-Feb-2004 | 00000 0000 | 0000 | Therapeutic Devices | |
000000 000000 | 04-Mar-2002 | 00000 0000 | 0000 | Therapeutic Devices | |
Aegera Therapeutics | Seed Round | Therapeutic Devices |
Nautilus Neurosciences Exits (4)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000 0000000000000 | 14-Dec-2009 | 0000000000 | Completed |
|
|
000000 00000000000 | 24-Feb-2004 | 00000 00000 00 | 0000 | Completed |
|
000000 00000000000 | 04-Mar-2002 | 00000 00000 00 | 0000 | Completed |
|
Aegera Therapeutics | Seed Round | Completed |
|